<DOC>
	<DOCNO>NCT01323582</DOCNO>
	<brief_summary>Erythromycin effectively use treatment Gastroparesis ( GP ) patient . In susceptible patient however , associate sudden cardiac death due prolongation QT interval subsequent cardiac risk interaction drug . Azithromycin ( AZI ) macrolide antibiotic mention druf interaction , few gastrointestinal side effect , few risk QT prolongation cardiac arrhythmia . Consequently , AZI avoid drawback dose erythromycin may prefer prokinetic agent patient concomitant medication . We hope demonstrate effectiveness Azithromycin ( AZI ) compare Erythromycin treatment Gastroparesis ( GP ) , later , form framework large randomized-controlled parallel study investigate use AZI treatment GP . Our novel hypothesis determine whether AZI use treat GP .</brief_summary>
	<brief_title>Comparison Two Macrolides , Azithromycin Erythromycin , Symptomatic Treatment Gastroparesis</brief_title>
	<detailed_description>Gastroparesis ( GP ) chronic gastrointestinal motility disorder result delay transit gastric content stomach duodenum absence mechanical outlet obstruction . The symptom GP variable include early satiety , bloating , nausea , vomit , epigastric abdominal pain . Although true prevalence disorder unknown , symptom suggestive GP present 7-15 % population estimate one-third diabetic patient tertiary care setting abnormal gastric empty study . Yet , despite significant healthcare economic cost due frequent hospitalization patient , treatment GP difficult due lack available treatment option often potential side effect available prokinetic agent , include cardiac side effect QT prolongation , sudden cardiac death , torsade de pointes . One medication use treatment GP erythromycin . Erythromycin drawback . Several report cardiac arrhythmias associate use either oral intravenous ( IV ) Erythromycin report . This finding spark interest another macrolide , Azithromycin ( AZI ) , drug-drug interaction see erythromycin metabolize CYP3A inhibitor , therefore few cardiac side effect . In This study primary goal determine whether AZI use treat GP .</detailed_description>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<criteria>present gastroenterology motility specialty clinic University Florida ( UF ) , meet clinical radiologic diagnostic criterion diagnosis GP Any history mechanical obstruction Gastrointestinal malignancy Current use prokinetics cisapride , pimozide , anticholinergic medication discontinue 72 hr prior study Abnormal upper endoscopy find erosion ulceration Helicobacter pylori infection past 6 month Recent abdominal surgery &lt; 6 month Cardiac history EKG find QTC &gt; 450 do screen test Detected renal hepatic dysfunction describe GFR &lt; 10 ml/min ALT/AST value &gt; 2 time normal level laboratory Allergy macrolide antibiotic Psychiatric history anxiety depression Predominant symptom irritable bowel syndrome constipation diarrhea Uncontrolled diabetes fast blood glucose level &gt; 180 mg/dL , due effect hyperglycemia gastric empty . For patient diabetes , blood glucose level record patient diary . Pregnant nursing female Any history myasthenia gravis Current use Coumadin , lovastatin , simvastatin Nelfinavir , theophylline , digoxin , ergotamine/dihydroergotamine product , benzodiazepine , sildenafil ( discontinue duration clinical trial subject medication ) . History elevate liver function study CPKs . Pregnancy : A urine pregnancy test perform begin treatment period subject pregnant enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Gastroparesis</keyword>
	<keyword>Gastroparesis Treatment</keyword>
	<keyword>Gastric Emptying</keyword>
	<keyword>Prokinetic Agents</keyword>
	<keyword>Macrolides</keyword>
	<keyword>Erythromycin</keyword>
	<keyword>Azithromycin</keyword>
	<keyword>Erythromycin Cardiac Side-effects</keyword>
	<keyword>Erythromycin drug interaction</keyword>
	<keyword>AZI</keyword>
</DOC>